img

Global Drug of Abuse (DOA) Testing Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug of Abuse (DOA) Testing Market Insights, Forecast to 2034

The drug of abuse test is an immunoassay based on the principle of competitive binding. 
Market Analysis and InsightsGlobal Drug of Abuse (DOA) Testing Market
Global Drug of Abuse (DOA) Testing market is expected to reach to US$ 6539 million in 2023, with a positive growth of %, compared with US$ 6321 million in 2022. Backed with the increasing demand from downstream industries, Drug of Abuse (DOA) Testing industry is evaluated to reach US$ 9703.7 million in 2033. The CAGR will be 6.8% during 2023 to 2033.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Covers
This report presents an overview of global Drug of Abuse (DOA) Testing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Drug of Abuse (DOA) Testing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others

Segment by Application


Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drug of Abuse (DOA) Testing introduction, etc. Drug of Abuse (DOA) Testing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Drug of Abuse (DOA) Testing
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Urine
1.2.3 Saliva
1.2.4 Hair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2018-2033)
2.2 Global Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Drug of Abuse (DOA) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drug of Abuse (DOA) Testing Historic Market Size by Region (2018-2023)
2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2024-2033)
2.3 Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 Drug of Abuse (DOA) Testing Industry Trends
2.3.2 Drug of Abuse (DOA) Testing Market Drivers
2.3.3 Drug of Abuse (DOA) Testing Market Challenges
2.3.4 Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug of Abuse (DOA) Testing by Players
3.1.1 Global Drug of Abuse (DOA) Testing Revenue by Players (2018-2023)
3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug of Abuse (DOA) Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2022
3.5 Global Key Players of Drug of Abuse (DOA) Testing Head office and Area Served
3.6 Global Key Players of Drug of Abuse (DOA) Testing, Product and Application
3.7 Global Key Players of Drug of Abuse (DOA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2018-2023)
4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2033)
5 Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2018-2023)
5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug of Abuse (DOA) Testing Market Size (2018-2033)
6.2 North America Drug of Abuse (DOA) Testing Market Size by Type
6.2.1 North America Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
6.2.2 North America Drug of Abuse (DOA) Testing Market Size by Type (2024-2033)
6.2.3 North America Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
6.3 North America Drug of Abuse (DOA) Testing Market Size by Application
6.3.1 North America Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
6.3.2 North America Drug of Abuse (DOA) Testing Market Size by Application (2024-2033)
6.3.3 North America Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
6.4 North America Drug of Abuse (DOA) Testing Market Size by Country
6.4.1 North America Drug of Abuse (DOA) Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
6.4.3 North America Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Market Size (2018-2033)
7.2 Europe Drug of Abuse (DOA) Testing Market Size by Type
7.2.1 Europe Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
7.2.2 Europe Drug of Abuse (DOA) Testing Market Size by Type (2024-2033)
7.2.3 Europe Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Application
7.3.1 Europe Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
7.3.2 Europe Drug of Abuse (DOA) Testing Market Size by Application (2024-2033)
7.3.3 Europe Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country
7.4.1 Europe Drug of Abuse (DOA) Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
7.4.3 Europe Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug of Abuse (DOA) Testing Market Size (2018-2033)
8.2 China Drug of Abuse (DOA) Testing Market Size by Type
8.2.1 China Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
8.2.2 China Drug of Abuse (DOA) Testing Market Size by Type (2024-2033)
8.2.3 China Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
8.3 China Drug of Abuse (DOA) Testing Market Size by Application
8.3.1 China Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
8.3.2 China Drug of Abuse (DOA) Testing Market Size by Application (2024-2033)
8.3.3 China Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Drug of Abuse (DOA) Testing Market Size (2018-2033)
9.2 Asia Drug of Abuse (DOA) Testing Market Size by Type
9.2.1 Asia Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
9.2.2 Asia Drug of Abuse (DOA) Testing Market Size by Type (2024-2033)
9.2.3 Asia Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
9.3 Asia Drug of Abuse (DOA) Testing Market Size by Application
9.3.1 Asia Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
9.3.2 Asia Drug of Abuse (DOA) Testing Market Size by Application (2024-2033)
9.3.3 Asia Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
9.4 Asia Drug of Abuse (DOA) Testing Market Size by Region
9.4.1 Asia Drug of Abuse (DOA) Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Drug of Abuse (DOA) Testing Market Size by Region (2018-2023)
9.4.3 Asia Drug of Abuse (DOA) Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.1.5 Siemens Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.3.5 Roche Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.5.5 Bio-Rad Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.6.5 Abbott Recent Developments
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.7.5 Quest Diagnostics Recent Developments
11.8 Psychemedics
11.8.1 Psychemedics Company Details
11.8.2 Psychemedics Business Overview
11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2018-2023)
11.8.5 Psychemedics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Urine
Table 3. Key Players of Saliva
Table 4. Key Players of Hair
Table 5. Key Players of Others
Table 6. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Drug of Abuse (DOA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Drug of Abuse (DOA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Drug of Abuse (DOA) Testing Market Share by Region (2018-2023)
Table 10. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Drug of Abuse (DOA) Testing Market Share by Region (2024-2033)
Table 12. Drug of Abuse (DOA) Testing Market Trends
Table 13. Drug of Abuse (DOA) Testing Market Drivers
Table 14. Drug of Abuse (DOA) Testing Market Challenges
Table 15. Drug of Abuse (DOA) Testing Market Restraints
Table 16. Global Drug of Abuse (DOA) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Drug of Abuse (DOA) Testing Revenue Share by Players (2018-2023)
Table 18. Global Top Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2022)
Table 19. Global Drug of Abuse (DOA) Testing Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Drug of Abuse (DOA) Testing, Headquarters and Area Served
Table 22. Global Key Players of Drug of Abuse (DOA) Testing, Product and Application
Table 23. Global Key Players of Drug of Abuse (DOA) Testing, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2023)
Table 27. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2024-2033)
Table 29. Global Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Drug of Abuse (DOA) Testing Revenue Share by Application (2018-2023)
Table 31. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Drug of Abuse (DOA) Testing Revenue Share by Application (2024-2033)
Table 33. North America Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Drug of Abuse (DOA) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Drug of Abuse (DOA) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Drug of Abuse (DOA) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Drug of Abuse (DOA) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Drug of Abuse (DOA) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Drug of Abuse (DOA) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Drug of Abuse (DOA) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Drug of Abuse (DOA) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Drug of Abuse (DOA) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Drug of Abuse (DOA) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Drug of Abuse (DOA) Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Drug of Abuse (DOA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Drug of Abuse (DOA) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 65. Siemens Company Details
Table 66. Siemens Business Overview
Table 67. Siemens Drug of Abuse (DOA) Testing Product
Table 68. Siemens Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 69. Siemens Recent Developments
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Drug of Abuse (DOA) Testing Product
Table 73. Merck Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 74. Merck Recent Developments
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Drug of Abuse (DOA) Testing Product
Table 78. Roche Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 79. Roche Recent Developments
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product
Table 83. Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 84. Thermo Fisher Scientific Recent Developments
Table 85. Bio-Rad Company Details
Table 86. Bio-Rad Business Overview
Table 87. Bio-Rad Drug of Abuse (DOA) Testing Product
Table 88. Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 89. Bio-Rad Recent Developments
Table 90. Abbott Company Details
Table 91. Abbott Business Overview
Table 92. Abbott Drug of Abuse (DOA) Testing Product
Table 93. Abbott Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 94. Abbott Recent Developments
Table 95. Quest Diagnostics Company Details
Table 96. Quest Diagnostics Business Overview
Table 97. Quest Diagnostics Drug of Abuse (DOA) Testing Product
Table 98. Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 99. Quest Diagnostics Recent Developments
Table 100. Psychemedics Company Details
Table 101. Psychemedics Business Overview
Table 102. Psychemedics Drug of Abuse (DOA) Testing Product
Table 103. Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 104. Psychemedics Recent Developments
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Drug of Abuse (DOA) Testing Market Share by Type: 2022 VS 2033
Figure 3. Urine Features
Figure 4. Saliva Features
Figure 5. Hair Features
Figure 6. Others Features
Figure 7. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Drug of Abuse (DOA) Testing Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Laboratories Case Studies
Figure 11. Workplace Case Studies
Figure 12. At-Home Case Studies
Figure 13. Others Case Studies
Figure 14. Drug of Abuse (DOA) Testing Report Years Considered
Figure 15. Global Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Drug of Abuse (DOA) Testing Market Share by Region: 2022 VS 2033
Figure 18. Global Drug of Abuse (DOA) Testing Market Share by Players in 2022
Figure 19. Global Top Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Drug of Abuse (DOA) Testing Revenue in 2022
Figure 21. North America Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
Figure 23. North America Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
Figure 24. North America Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 25. United States Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Drug of Abuse (DOA) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
Figure 29. Europe Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
Figure 30. Europe Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 31. Germany Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Drug of Abuse (DOA) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
Figure 39. China Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
Figure 40. Asia Drug of Abuse (DOA) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
Figure 42. Asia Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
Figure 43. Asia Drug of Abuse (DOA) Testing Market Share by Region (2018-2033)
Figure 44. Japan Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 54. Brazil Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Siemens Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 61. Merck Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 62. Roche Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 64. Bio-Rad Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 65. Abbott Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 66. Quest Diagnostics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 67. Psychemedics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries